<DOC>
	<DOCNO>NCT00002479</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness tretinoin treat patient stage mycosis fungoides Sezary syndrome .</brief_summary>
	<brief_title>Tretinoin Treating Patients With Mycosis Fungoides Sezary Syndrome</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy tretinoin ( TRA ) patient mycosis fungoides/Sezary syndrome . II . Evaluate spectrum toxicity TRA patient population . OUTLINE : Nonrandomized study . Single-agent Chemotherapy . Tretinoin , All-trans-Retinoic Acid , TRA , NSC-122758 . PROJECTED ACCRUAL : If 1 first 15 evaluable patient experience objective response , 20 additional patient enter . It anticipate accrual rate 1-2 patient per month .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Mycosis Fungoides</mesh_term>
	<mesh_term>Sezary Syndrome</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Biopsyproven mycosis fungoides/Sezary syndrome Stage IIV disease No CNS involvement At least 1 measurable lesion require ( skin , lymph node , visceral lesion , peripheral blood count ) PATIENT CHARACTERISTICS : Age : Over 18 Performance status : ECOG 03 Hematopoietic : WBC least 3,000/mm3 Platelet count least 75,000/mm3 Hepatic : Bilirubin 2.0 mg/dL Transaminases 2 x normal Alkaline phosphatase 2 x normal Renal : Creatinine 2.0 mg/dL Other : No active systemic infection No significant organ failure uncontrolled medication No pregnant lactate woman Effective contraception require fertile woman PRIOR CONCURRENT THERAPY : Biologic therapy : At least 4 week since prior systemic therapy Chemotherapy : At least 4 week since prior topical chemotherapeutics systemic therapy Endocrine therapy : At least 4 week since prior topical ( include steroid ) therapy systemic therapy Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>stage I cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage II cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage III cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage IV cutaneous T-cell non-Hodgkin lymphoma</keyword>
</DOC>